Login to Your Account

Pharma: Other News To Note

Wednesday, November 6, 2013
• Pfizer Inc., of New York, said the FDA approved a prior approval supplement for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release capsules CII.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription